Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Kawamoto

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 9, 2025
[Diagnosing Crohn's disease]Ami Kawamoto, Kento Takenaka, Ryuichi Okamoto
Alimentary Pharmacology & Therapeutics|September 26, 2021
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' replyKento Takenaka, Ami Kawamoto, Kazuo Ohtsuka
Internal Medicine (Tokyo, Japan)|April 1, 2026
Severe Pancreatic Leakage post-EUS-TA Associated with Pancreatic DivisumHiromune Katsuda, Takahiro Shin, Ami Kawamoto, et al.
Intestinal Research|January 6, 2022
Artificial intelligence for endoscopy in inflammatory bowel diseaseKento Takenaka, Ami Kawamoto, Ryuichi Okamoto, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 20, 2022
Systematic review of artificial intelligence-based image diagnosis for inflammatory bowel diseaseAmi Kawamoto, Kento Takenaka, Ryuichi Okamoto, et al.
Inflammatory Bowel Diseases|June 14, 2022
Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative ColitisAmi Kawamoto, Toshimitsu Fujii, Ryuji Mitani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
Serum Leucine-Rich α<sub>2</sub> Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn's DiseaseAmi Kawamoto, Kento Takenaka, Shuji Hibiya, et al.
Clinical Journal of Gastroenterology|August 24, 2023
Sphincter of Oddi dysfunction that could not be diagnosed with Rome IV: a case reportNanako Hashido, Masanori Kobayashi, Ami Kawamoto, et al.
Intestinal Research|November 8, 2023
Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopyAmi Kawamoto, Kento Takenaka, Shuji Hibiya, et al.
Inflammatory Bowel Diseases|February 10, 2026
Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohortKento Takenaka, Ami Kawamoto, Shuji Hibiya, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|July 9, 2025
[Diagnosing Crohn's disease]Ami Kawamoto, Kento Takenaka, Ryuichi Okamoto
Alimentary Pharmacology & Therapeutics|September 26, 2021
Editorial: higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease-authors' replyKento Takenaka, Ami Kawamoto, Kazuo Ohtsuka
Internal Medicine (Tokyo, Japan)|April 1, 2026
Severe Pancreatic Leakage post-EUS-TA Associated with Pancreatic DivisumHiromune Katsuda, Takahiro Shin, Ami Kawamoto, et al.
Intestinal Research|January 6, 2022
Artificial intelligence for endoscopy in inflammatory bowel diseaseKento Takenaka, Ami Kawamoto, Ryuichi Okamoto, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|April 20, 2022
Systematic review of artificial intelligence-based image diagnosis for inflammatory bowel diseaseAmi Kawamoto, Kento Takenaka, Ryuichi Okamoto, et al.
Inflammatory Bowel Diseases|June 14, 2022
Serum Levels of Infliximab Biosimilar in a Child Delivered From a Mother Treated for Ulcerative ColitisAmi Kawamoto, Toshimitsu Fujii, Ryuji Mitani, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2021
Serum Leucine-Rich α<sub>2</sub> Glycoprotein: A Novel Biomarker For Small Bowel Mucosal Activity in Crohn's DiseaseAmi Kawamoto, Kento Takenaka, Shuji Hibiya, et al.
Clinical Journal of Gastroenterology|August 24, 2023
Sphincter of Oddi dysfunction that could not be diagnosed with Rome IV: a case reportNanako Hashido, Masanori Kobayashi, Ami Kawamoto, et al.
Intestinal Research|November 8, 2023
Combination of leucine-rich alpha-2 glycoprotein and fecal markers detect Crohn's disease activity confirmed by balloon-assisted enteroscopyAmi Kawamoto, Kento Takenaka, Shuji Hibiya, et al.
Inflammatory Bowel Diseases|February 10, 2026
Stricture dynamics and prognosis during biologic therapy in ileal Crohn's disease: a real-world cohortKento Takenaka, Ami Kawamoto, Shuji Hibiya, et al.
Pageof 5